Genotypic analysis in primary systemic anaplastic large cell lymphoma

Pathology and Oncology Research

Volumn 9, Issue 2, 2003, Pages 104-106

  Szomor, Árpád ^a   Zenou, Prune ^b   Roda, Daniel ^b   Al Saati, Talal ^b   Csanaky, György ^c   Pajor, László ^a   Kelényi, Gábor ^a   Delsol, Georges ^b   Losonczy, Hajna ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b CHU PURPAN   (France)

^c Markusovszky Teaching Hospital   (Hungary)

Author keywords

Anaplastic large cell lymphoma; IgH gene rearrangement; T(2; 5)(p23; q35) and t(1; 2)(q25; p23) translocation; TCR and gene rearrangement

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN;

ADOLESCENT; ADULT; AGED; ANAPLASTIC LARGE CELL LYMPHOMA; ARTICLE; CHILD; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; FEMALE; GENE; GENE REARRANGEMENT; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; MALE; MOLECULAR GENETICS; NULL CELL; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T CELL RECEPTOR BETA GENE; T CELL RECEPTOR GAMMA GENE;

EID: 0042659129     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033753     Document Type: Article

References (10)

1. Falini B: Anaplastic large cell lymphoma: pathological, molecular and clinical features. Br J Haematol 114:741-760, 2001.
2. Harris NL, Jaffe ES, Diebold J, et al: World Health Organization classification of neoplastic diseases of the hematopoetic and lymphoid tissues: report of the Clinical Advisory Committee Meeting - Airlie House, Virginia, November 1997. J Clin Oncol 17: 3835-3849, 1999.
3. Lamant L, Dastugue N, Pulford K, et al: A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation. Blood 93: 3088-3095, 1999.
4. Lamant L, Meggetto F, Al Saati T, et al: High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse trancriptase-polymerase chain reaction, and P-80 immunostaining. Blood 87: 284-291, 1996.
5. Morris SW, Kirstein MN, Valentine MB, et al: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in nonHodgkin's lymphoma. Science 263: 1281-1284, 1994.
6. Nagy M, Fehér K, László T, et al: Analysis of T-cell receptor 7-gene rearrangement in lymphoproliferative disorders using polymerase chain reaction. Orv Hetil 140: 2441-2444, 1999.
7. Pulford K, Lamant L, Morris SW, et al: Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALKI. Blood 89: 1394-1404, 1997.
8. Stein H, Foss HD, Dürkop H, et al: CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic and clinical features. Blood 96: 3681-3695, 2000.
9. Stein H, Mason DY, Gerdes J, et al: The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Stemberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66: 848-858, 1985.
10. Theriault C, Galoin S, Valmary S, et al: PCR analysis of immunoglobulin heavy chain (IgH) and TcR-gamma chain rearrangements in the diagnosis of lymphoproliferative disorders of a study of 525 cases. Mod Pathol 13: 1269-1279, 2000.